Meeting NewsVideo

VIDEO: Barry Katzen, MD, highlights the changing landscape of endovascular therapy

HOLLYWOOD, Fla. — In this video exclusive, Barry T. Katzen, MD, provides a snapshot of three important areas in endovascular therapy right now: a move toward patient-centered care, the epidemic of critical limb ischemia and treatment of pulmonary emboli.

The field of medicine, in general, appears to be moving toward much more patient-centered care, wherein patients know more about themselves and their treatment options and will be much more engaged in decision making, according to Katzen, the founder and chief medical executive of Miami Cardiac and Vascular Institute at Baptist Health South Florida and lead program director for the International Symposium on Endovascular Therapy (ISET).

As president of the CLI Global Society, Katzen also emphasizes the importance of greater awareness of CLI, which is “reaching epidemic proportions.”

The new field of treating pulmonary emboli also continues to garner interest, according to Katzen. “We are not only prolonging life by more aggressive, early treatment, but also reducing some of the very terrible things that can occur to patients long-term as a result of chronic pulmonary embolism,” he told Cardiology Today’s Intervention.

Watch the full video as Katzen describes other highlights from the 30th anniversary of ISET.

HOLLYWOOD, Fla. — In this video exclusive, Barry T. Katzen, MD, provides a snapshot of three important areas in endovascular therapy right now: a move toward patient-centered care, the epidemic of critical limb ischemia and treatment of pulmonary emboli.

The field of medicine, in general, appears to be moving toward much more patient-centered care, wherein patients know more about themselves and their treatment options and will be much more engaged in decision making, according to Katzen, the founder and chief medical executive of Miami Cardiac and Vascular Institute at Baptist Health South Florida and lead program director for the International Symposium on Endovascular Therapy (ISET).

As president of the CLI Global Society, Katzen also emphasizes the importance of greater awareness of CLI, which is “reaching epidemic proportions.”

The new field of treating pulmonary emboli also continues to garner interest, according to Katzen. “We are not only prolonging life by more aggressive, early treatment, but also reducing some of the very terrible things that can occur to patients long-term as a result of chronic pulmonary embolism,” he told Cardiology Today’s Intervention.

Watch the full video as Katzen describes other highlights from the 30th anniversary of ISET.

    See more from International Symposium on Endovascular Therapy